Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Zhonghua Yi Xue Za Zhi
|
January 19, 2013
[Prognostic value of maximum standard uptake on pretreatment 18F-FDG PET/CT scan in newly diagnosed diffuse large B cell lymphoma]
Zhi-tao Ying, Xue-juan Wang, Yu-qin Song, et al.
Annals of Hematology
|
November 1, 2017
Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphoma
Wei Ping Liu, Xiao Pei Wang, Wen Zheng, et al.
Ejhaem
|
December 5, 2022
Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non-germinal centre B-cell-like diffuse large B-cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial
Jun Zhu, Xiaonan Hong, Yu Qin Song, et al.
International Journal of Cancer
|
August 4, 2023
Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study
Yu-Ce Wei, Fei Qi, Bao-Min Zheng, et al.
Annals of Hematology
|
October 10, 2023
Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study
Yu-Ce Wei, Wei-Xin Liu, Fei Qi, et al.
Journal of Hematology & Oncology
|
November 19, 2013
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group
Seok Jin Kim, Hyun Ae Jung, Shih-Sung Chuang, et al.
Annals of Hematology
|
May 28, 2024
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China
Wei Wang, Wei Zhang, Li-Ping Su, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2013
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group
Seok Jin Kim, Chiun Hsu, Yu-Qin Song, et al.
Blood Advances
|
February 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults
Yan Xie, Ke-Shu Zhou, Lan-Fang Li, et al.
Cancer Reports (Hoboken, N.J.)
|
March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma
Jia-Xin Liu, Xin Liu, Yong Yang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Zhonghua Yi Xue Za Zhi
|
January 19, 2013
[Prognostic value of maximum standard uptake on pretreatment 18F-FDG PET/CT scan in newly diagnosed diffuse large B cell lymphoma]
Zhi-tao Ying, Xue-juan Wang, Yu-qin Song, et al.
Annals of Hematology
|
November 1, 2017
Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphoma
Wei Ping Liu, Xiao Pei Wang, Wen Zheng, et al.
Ejhaem
|
December 5, 2022
Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non-germinal centre B-cell-like diffuse large B-cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial
Jun Zhu, Xiaonan Hong, Yu Qin Song, et al.
International Journal of Cancer
|
August 4, 2023
Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study
Yu-Ce Wei, Fei Qi, Bao-Min Zheng, et al.
Annals of Hematology
|
October 10, 2023
Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study
Yu-Ce Wei, Wei-Xin Liu, Fei Qi, et al.
Journal of Hematology & Oncology
|
November 19, 2013
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group
Seok Jin Kim, Hyun Ae Jung, Shih-Sung Chuang, et al.
Annals of Hematology
|
May 28, 2024
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China
Wei Wang, Wei Zhang, Li-Ping Su, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 6, 2013
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group
Seok Jin Kim, Chiun Hsu, Yu-Qin Song, et al.
Blood Advances
|
February 24, 2026
Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults
Yan Xie, Ke-Shu Zhou, Lan-Fang Li, et al.
Cancer Reports (Hoboken, N.J.)
|
March 15, 2023
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma
Jia-Xin Liu, Xin Liu, Yong Yang, et al.
Page
of 6